Datasheet
12 Oct 2022
Full Solution Provider for Animal Derived Extracts
PDF 390 kB
Nordmark Pharma is offering an all-in-one solution for animalderived extracts covering the entire value chain from processdevelopment, analytics, production of API and finished drug productup to regulatory affairs and marketing authorisation. Our worldwidecustomers benefit from this integrated approach, which is basedon solid project management, long-standing GMP experience,biosafety expertise and recurrent EMA and FDA approvals.
Content provided by our supplier
Nordmark Pharma GmbH
-
Country/Region:Germany
-
On CPHI since:2015
-
Certificates:2
-
Employees:500 - 999
Company types
Primary activities
Other Content from Nordmark Pharma GmbH (3)
-
Brochure Full Solution Provider for Microbial Fermentation
Nordmark Biotech bundles all biotechnological activities ofNordmark. We are offering an all-in-one solution for microbialfermentation based products covering the entire value chain fromprocess development, analytics, production of API and finisheddrug product up to regulatory affairs and marketing authorisation.Our worldwide customers benefit from this integrated approach,which is based on solid project management, long-standing GMPexperience and recurrent EMA and FDA approvals. -
Brochure Full Solution Provider for Mammalian Cell Culture
Nordmark Biotech bundles all biotechnological activities ofNordmark. We are offering an all-in-one solution for mammaliancell culture based products covering the entire value chain fromprocess development, analytics, production of API and finisheddrug product up to regulatory affairs and marketing authorisation.Our worldwide customers benefit from this integrated approach,which is based on solid project management, long-standing GMPexperience and recurrent EMA and FDA approvals. -
Datasheet Full Solution Provider for Live Biotherapeutics
Nordmark Biotech bundles all biotechnological activities ofNordmark. We are offering an all-in-one solution for microbiomebased products covering the entire value chain from process development,analytics, production of drug substance (DS) and finisheddrug product (DP) up to regulatory affairs and marketing authorisation.Our worldwide customers benefit from this integrated approach,which is based on solid project management, long-standing GMPexpertise and recurrent EMA and FDA approvals.